Abstract:A virologic marker, the number of HIV RNA copies or viral load, is currently used to evaluate antiretroviral (ARV) therapies in AIDS clinical trials. This marker can be used to assess the ARV potency of therapies, but is easily affected by drug exposures, drug resistance and other factors during the long-term treatment evaluation process. HIV dynamic studies have significantly contributed to the understanding of HIV pathogenesis and ARV treatment strategies. However, the models of these studies are used to quantify short-term HIV dynamics ($<$ 1 month), and are not applicable to describe long-term virological response to ARV treatment due to the difficulty of establishing a relationship of antiviral response with multiple treatment factors such as drug exposure and drug susceptibility during long-term treatment. Long-term therapy with ARV agents in HIV-infected patients often results in failure to suppress the viral load. Pharmacokinetics (PK), drug resistance and imperfect adherence to prescribed antiviral drugs are important factors explaining the resurgence of virus. To better understand the factors responsible for the virological failure, this paper develops the mechanism-based nonlinear differential equation models for characterizing long-term viral dynamics with ARV therapy. The models directly incorporate drug concentration, adherence and drug susceptibility into a function of treatment efficacy and, hence, fully integrate virologic, PK, drug adherence and resistance from an AIDS clinical trial into the analysis. A Bayesian nonlinear mixed-effects modeling approach in conjunction with the rescaled version of dynamic differential equations is investigated to estimate dynamic parameters and make inference. In addition, the correlations of baseline factors with estimated dynamic parameters are explored and some biologically meaningful correlation results are presented. Further, the estimated dynamic parameters in patients with virologic success were compared to those in patients with virologic failure and significantly important findings were summarized. These results suggest that viral dynamic parameters may play an important role in understanding HIV pathogenesis, designing new treatment strategies for long-term care of AIDS patients.

Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome

Jointly Modelling Longitudinal and Survival Data

Mixed-Effects Varying-Coefficient Model with Skewed Distribution Coupled with Cause-Specific Varying-Coefficient Hazard Model with Random-Effects for Longitudinal-Competing Risks Data Analysis

Joint model-based clustering of nonlinear longitudinal trajectories and associated time-to-event data analysis, linked by latent class membership: with application to AIDS clinical studies

Simultaneous Inference for HIV Dynamic Models with Skew-t Distribution Incorporating Mismeasured Covariate and Multiple Treatment Factors

HIV dynamics and natural history studies: Joint modeling with doubly interval-censored event time and infrequent longitudinal data

Joint Modeling for Mixed-Effects Quantile Regression of Longitudinal Data with Detection Limits and Covariates Measured with Error, with Application to AIDS Studies

Joint analysis of nonlinear heterogeneous longitudinal data and binary outcome: an application to AIDS clinical studies

Joint Dispersion Model with a Flexible Link

Joint Dynamic Models and Statistical Inference for Recurrent Competing Risks, Longitudinal Marker, and Health Status

[Introduction of Joint Model and Its Applications in Medical Research].

Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study

A Bayesian joint longitudinal-survival model with a latent stochastic process for intensive longitudinal data

Joint modeling of zero-inflated longitudinal measurements and time-to-event outcomes with applications to dynamic prediction

Extension of the Gradient Boosting Algorithm for Joint Modeling of Longitudinal and Time-to-Event data

A joint model for (un)bounded longitudinal markers, competing risks, and recurrent events using patient registry data

Bayesian joint analysis of heterogeneous- and skewed-longitudinal data and a binary outcome, with application to AIDS clinical studies

Bayesian Varying Coefficient Mixed-Effects Joint Models with Asymmetry and Missingness

A dynamic Bayesian nonlinear mixed-effects model of HIV response incorporating medication adherence, drug resistance and covariates

Joint models for the longitudinal analysis of measurement scales in the presence of informative dropout

JOINT MODELING OF MULTISTATE AND NONPARAMETRIC MULTIVARIATE LONGITUDINAL DATA